Month: June 2025

Medicare Expands Signatera Genome MRD Assay Coverage

Posted by Shajini | Jun 6, 2025 | News, Pricing & Market Access

Medicare has approved coverage for Natera’s genome-based Signatera molecular residual disease (MRD) assay under LCD L38779, extending access to beneficiaries across six cancer indications. The coverage applies to...

Read More

CND’s Syn-One Test Shows 75% Detection in Sleep Disorder

Posted by Shajini | Jun 6, 2025 | MedTech, News

CND Life Sciences reported baseline results from its NIH-sponsored Syn-Sleep Study, demonstrating the Syn-One Test’s ability to detect phosphorylated alpha-synuclein (P-SYN) in 75% of patients with idiopathic REM sleep...

Read More

1
…
7
8
9